These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4736049)

  • 1. European Symposium on Clinical Pharmacological Evaluation in Drug Control, Heidelberg 27.-30. XI. 1972.
    Andersen AH; Antonsen S
    Ugeskr Laeger; 1973 Mar; 135(12):651-3. PubMed ID: 4736049
    [No Abstract]   [Full Text] [Related]  

  • 2. [European drug market--dream or nightmare?].
    Nord Med; 1974 Jan; 89(1):6-8. PubMed ID: 4819431
    [No Abstract]   [Full Text] [Related]  

  • 3. EURAP: an international registry of antiepileptic drugs and pregnancy.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Vajda F;
    Epilepsia; 2004 Nov; 45(11):1463-4. PubMed ID: 15509250
    [No Abstract]   [Full Text] [Related]  

  • 4. Third European Symposium on Clinical Pharmoacological Evaluation in Drug Control.
    Andersen AH; Antonsen S
    Ugeskr Laeger; 1975 Jan; 137(5):273-4. PubMed ID: 1136035
    [No Abstract]   [Full Text] [Related]  

  • 5. International collaborative study to assess candidate reference preparations to control the level of anti-D in IVIG for use in Europe and the United States.
    Thorpe SJ; Fox B; Heath A; Behr-Gross ME; Virata ML; Yu MY
    Biologicals; 2006 Sep; 34(3):209-12. PubMed ID: 16492398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European regulatory authorities and pediatric labeling.
    Autret E
    Pediatrics; 1999 Sep; 104(3 Pt 2):614-8. PubMed ID: 10469802
    [No Abstract]   [Full Text] [Related]  

  • 7. Europe, U.S. cooperate on drug regulation.
    Reinke T
    Manag Care; 2011 Jan; 20(1):10. PubMed ID: 21309395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Are children getting the right drugs?].
    Bratlid D
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3290-2. PubMed ID: 16327857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug problems and the Common Market. Personal views].
    Andersen AH
    Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706
    [No Abstract]   [Full Text] [Related]  

  • 11. 2000: the drug problem in the European Union.
    Murphy JF
    Ir Med J; 2000 Dec; 93(9):260. PubMed ID: 11209906
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isotretinoin and pregnancy].
    Revuz J
    Ann Dermatol Venereol; 2000 Oct; 127(10):797-8. PubMed ID: 11060380
    [No Abstract]   [Full Text] [Related]  

  • 13. Fourth European Symposium on Clinical Pharmacological Evaluation in Drug Control. Deidesheim, Vesttyskland, 11.-14.XI.1975.
    Andersen AH; Antonsen S; Hvidberg E
    Ugeskr Laeger; 1976 Mar; 138(10):624-6. PubMed ID: 3006
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving international drug cooperation.
    Voss EH
    Am Pharm; 1980 Apr; NS20(4):8-9. PubMed ID: 7386381
    [No Abstract]   [Full Text] [Related]  

  • 15. [European efforts in drug problems].
    Bertschinger JP
    Ther Umsch; 1971 Apr; 28(4):220-5. PubMed ID: 5575079
    [No Abstract]   [Full Text] [Related]  

  • 16. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA
    Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stages of the international drug control system.
    Carstairs C
    Drug Alcohol Rev; 2005 Jan; 24(1):57-65. PubMed ID: 16191722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nordic cooperation on drug control, registration, information. A Gordian knot?].
    Naess K
    Nord Med; 1974 Jan; 89(1):1-2. PubMed ID: 4819426
    [No Abstract]   [Full Text] [Related]  

  • 19. Multi-level governance: The way forward for European illicit drug policy?
    Chatwin C
    Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What role can public health institutions play in drug development for the poor? A case study of artesunate.
    Gomes M; Olliaro P; Folb P
    Med Trop (Mars); 1998; 58(3 Suppl):97-100. PubMed ID: 10212912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.